Financial Times - May 17

May 17 (Reuters) - The following are the top stories in the Financial Times. Reuters has not verified these stories and does not vouch for their accuracy.


- Israeli electric vehicle group REE to build $15mn UK factory Link

- EY accused of basic failings in $2.7bn claim over NMC collapse Link

- Renault sells Russia business and stake in Lada maker for 2 roubles Link

- Pension lifeboat fund rules leave 83,000 with no cover for rising UK inflation Link


- Israeli electric vehicle start-up REE will open a $15 mln production facility in UK and plans to double its workforce in the country, in one of the first manufacturing investments from the new wave of makers.

- Ernst & Young failed to flag a multibillion dollar fraud at FTSE 100 group NMC Health in the years before its 2020 collapse because the auditor did not properly carry out basic checks, according to a $2.7bn legal claim by the hospital operator's administrators.

- Renault SA RENA.PA is selling its entire Russian operation including its stake in Lada-maker Avtovaz for 2 roubles, in one of the most significant retreats by a foreign company since the invasion of Ukraine.

- Ministers are being urged to review "grossly unfair" compensation arrangements affecting 83,000 elderly members of the UK's pension lifeboat fund as the cost of living soars.

(Compiled by Bengaluru newsroom)

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

We are using cookies to give you the best experience on our website. Read more or change your cookie settings.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.